Inclusion criteria | |
• Adult patients (aged ≥ 18 years) with acute ischemic stroke and atrial fibrillation | |
• Eligible and willing to start (or restart) NOAC | |
• Signed informed consent | |
Exclusion criteria | |
• Contraindication to NOAC (e.g. ongoing bleeding, mechanical heart valve prosthesis) | |
• Ongoing therapy with NOAC (without ≥ 2 days interruption at index stroke) | |
• INR > 1.7 | |
• No second brain imaging (CT/MRI) after thrombolysis/thrombectomy | |
• Previous randomisation in the TIMING study |